Key Takeaways
- • North American insurers' median private equity allocation declined to 2.3% in 2025 from 2.8% in 2024, while European insurers' allocation fell to 1.8% from 2.9%, marking the first year-over-year contraction in either region over the past five years.
- • EU-based private equity and venture capital firms invested $6.8 billion in domestic AI companies in 2025, representing an 83% increase year-over-year, signaling a major strategic pivot toward artificial intelligence investments within the European investment ecosystem.
- • Insurers are reducing private equity exposure due to prolonged exit challenges that have delayed profit realization, compounded by stricter European regulatory requirements mandating higher capital reserves against risky alternative investments.
- • Large alternative asset managers are acquiring insurers to capture cross-selling synergies and generate management fees, while strong earnings among property and casualty insurers provide substantial capital reserves for investment deployment.
Summary
Insurers on both sides of the Atlantic pulled back from private equity in 2025, with allocation declines across North America and Europe breaking a five-year streak of consecutive increases. North American insurers reduced their median private equity allocation to 2.3% of portfolios from 2.8% a year earlier, while European insurers contracted their exposure more sharply to 1.8% from 2.9%, according to S&P Global Market Intelligence analysis of Preqin data. This marks the first recorded year-over-year decline in either region since 2020.
The pullback stems from multiple headwinds pressuring insurer investment strategies. Extended holding periods in private equity funds have created an exit bottleneck, slowing the return of capital and profits to institutional investors. European insurers face additional regulatory constraints, particularly requirements to hold larger capital buffers against riskier alternative asset classes, which economically penalizes private equity commitments relative to more liquid or lower-risk investments.
Despite the near-term allocation contraction, institutional ties between private equity sponsors and insurers have strengthened structurally. Leading alternative asset managers have acquired insurance companies outright to unlock business model synergies—capturing investment management fees while deploying sponsor capital through the insurer's balance sheet. Strong underwriting earnings, particularly in property and casualty insurance, have bolstered insurer capital adequacy, providing dry powder for strategic commitments.
European investment capital is decisively rotating toward artificial intelligence. EU-based private equity and venture capital firms deployed $6.8 billion into domestic AI companies during 2025, an 83% surge from 2024 levels. This concentration of capital in AI-focused companies reflects a broader strategic reorientation across the European alternative investment landscape, positioning artificial intelligence as a primary allocation priority despite broader private equity allocation reductions among insurer portfolios.
The pullback stems from multiple headwinds pressuring insurer investment strategies. Extended holding periods in private equity funds have created an exit bottleneck, slowing the return of capital and profits to institutional investors. European insurers face additional regulatory constraints, particularly requirements to hold larger capital buffers against riskier alternative asset classes, which economically penalizes private equity commitments relative to more liquid or lower-risk investments.
Despite the near-term allocation contraction, institutional ties between private equity sponsors and insurers have strengthened structurally. Leading alternative asset managers have acquired insurance companies outright to unlock business model synergies—capturing investment management fees while deploying sponsor capital through the insurer's balance sheet. Strong underwriting earnings, particularly in property and casualty insurance, have bolstered insurer capital adequacy, providing dry powder for strategic commitments.
European investment capital is decisively rotating toward artificial intelligence. EU-based private equity and venture capital firms deployed $6.8 billion into domestic AI companies during 2025, an 83% surge from 2024 levels. This concentration of capital in AI-focused companies reflects a broader strategic reorientation across the European alternative investment landscape, positioning artificial intelligence as a primary allocation priority despite broader private equity allocation reductions among insurer portfolios.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.